Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aptevo Therapeutics (APVO) Return on Invested Capital (2016 - 2019)

Historic Return on Invested Capital for Aptevo Therapeutics (APVO) over the last 3 years, with Q3 2019 value amounting to 0.76%.

  • Aptevo Therapeutics' Return on Invested Capital changed N/A to 0.76% in Q3 2019 from the same period last year, while for Sep 2019 it was 0.76%, marking a year-over-year change of. This contributed to the annual value of 0.46% for FY2017, which is 12400.0% up from last year.
  • Aptevo Therapeutics' Return on Invested Capital amounted to 0.76% in Q3 2019.
  • Aptevo Therapeutics' 5-year Return on Invested Capital high stood at 0.36% for Q4 2017, and its period low was 1.98% during Q2 2017.
  • Its 3-year average for Return on Invested Capital is 1.14%, with a median of 0.76% in 2019.
  • Examining YoY changes over the last 5 years, Aptevo Therapeutics' Return on Invested Capital showed a top increase of 16000bps in 2017 and a maximum decrease of -13700bps in 2017.
  • Quarter analysis of 3 years shows Aptevo Therapeutics' Return on Invested Capital stood at 1.96% in 2016, then skyrocketed by 82bps to 0.36% in 2017, then tumbled by -112bps to 0.76% in 2019.
  • Its last three reported values are 0.76% in Q3 2019, 0.36% for Q4 2017, and 0.5% during Q3 2017.